BioMarin Reveals Dwarfism Study Data, Stock Soars

BioMarin Pharmaceuticals Inc. (NASDAQ:BMRN) stock is trading higher on Thursday as the company is celebrating positive results from its Phase 3 CANOPY-HCH-3 study for VOXZOGO (vosoritide) in children with hypochondroplasia. Hypochondroplasia is a form of genetic,...